Andrea Gillespie

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

Eva Dombi, Andrea Baldwin, Leigh Marcus et al. · New England Journal of Medicine · 2016 · 639 citations · Full text

NF1 plexiform neurofibroma growth rate by volumetric MRI

Eva Dombi, Jeffrey Solomon, Andrea Gillespie et al. · Neurology · 2007 · 191 citations

Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

Brigitte C. Widemann, Wanda L. Salzer, R.J. Arceci et al. · Journal of Clinical Oncology · 2006 · 145 citations · Full text

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas

Brigitte C. Widemann, Eva Dombi, Andrea Gillespie et al. · Neuro-Oncology · 2014 · 111 citations · Full text

Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social‐emotional functioning, and quality of life

Pamela L. Wolters, Katherine M. Burns, Staci Martin et al. · American Journal of Medical Genetics Part A · 2015 · 101 citations · Full text